Qvella

Qvella is a molecular diagnostics company with the goal of dramatically reducing time to results in bacteriology.

Qvella is widely recognized as highly desirable, has proved elusive yet holds the promise of revolutionizing how medicine is practiced by offering actionable results in clinically relevant time frames to improve patient outcomes and save lives.

Qvella was founded in 2009 and is based in Richmond Hill, Ontario, Canada.

 

Qvella's Field Activated Sample Treatment (FAST) technology utilizes a novel electrical lysing and sample treatment technique we call e-lysis'; enabling direct and fully-automated rapid detection of infectious agents from unenriched biological samples.

 

Qvella's Field Activated Sample Treatment (FAST™) technology utilizes a novel electrical lysing and sample treatment technique we call e-lysis™; enabling direct and fully-automated rapid detection of infectious agents from unenriched biological samples.

 

Qvella is backed by inveestors including RA Capital Management, Hatteras Venture Partners, Sands Capital Partners and others.

 

 

  • Year founded: 2009
  • Funding Info: $41.3M in 3 funding rounds (Last Funding Type: Series B)
  • Yearly Revenue: $10-$20M (2018)
  • Employee Size: 51-200
  • Business Valuation: NA
  • City/Town: Richmond Hill
  • State: Ontario
  • Country: Canada
Related businesses